FDA sets up council for post-market review of vaccines, gene therapies
The FDA said the council is intended to improve accountability and transparency as biologic products grow increasingly complex, particularly in cell and gene therapy, a sector that has seen rapid regulatory expansion in recent years
We haven't written up this one. The Hindu - Sci-Tech has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.